Trans-repressive effect of NUP98-PMX1 on PMX1-Regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats

被引:58
作者
Bai, Xue-Tao
Gu, Bai-Wei
Yin, Tong
Niu, Chao
Xi, Xiao-Dong
Zhang, Ji
Chen, Zhu
Chen, Sai-Juan
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hematol, Ruijin Hosp, Shanghai 200025, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Ruijin Hosp, Shanghai 200025, Peoples R China
关键词
D O I
10.1158/0008-5472.CAN-05-3101
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The formation of fusion genes between NUP98 and members of the HOX family represents a critical factor for the genesis of acute leukemia or acute transformation of chronic myeloid leukemia (CML). To gain insights into the molecular mechanisms underlying the leukemogenesis of NUP98-HOX fusion products, we cloned NUP98-PMX1 from a CML-blast crisis patient with t(1;11) as a secondary chromosomal translocation, and functionally studied the fusion products in detail through various molecular and protein biochemical assays. In addition to many interesting features, we have found that the NUP98-PMX1 fusion protein exerts a repressive effect on PMX1 or serum response factor-mediated c-FOS activation, probably through the recruitment of a common corepressor histone deacetylase 1 by FG domains of the NUP98-PMX1 fusion protein. Moreover, we have provided evidence that the FG domains of ATLT98-PMX1 and two other NUP98-containing fusion proteins, i.e., NUP98-HOXA9 and NtT98-HOXC11, all exhibit dual binding ability to both CRFB binding protein, a coactivator, and histone deacetylase 1, a corepressor. Accordingly, we have hypothesized that this dual binding activity is shared by most, if not all, NUP98-HOX-involved fusion proteins, enabling these fusion proteins to act as both transactivators and trans- repressors, and contributing to the genesis of acute leukemia or acute transformation of CML.
引用
收藏
页码:4584 / 4590
页数:7
相关论文
共 33 条
[1]  
BEL L, 2005, J BIOL CHEM, V280, P12359
[2]   The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow [J].
Bjerregaard, MD ;
Jurlander, J ;
Klausen, P ;
Borregaard, N ;
Cowland, JB .
BLOOD, 2003, 101 (11) :4322-4332
[3]   A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9 [J].
Dash, AB ;
Williams, IR ;
Kutok, JL ;
Tomasson, MH ;
Anastasiadou, E ;
Lindahl, K ;
Li, SG ;
Van Etten, RA ;
Borrows, J ;
Housman, D ;
Druker, B ;
Gilliland, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (11) :7622-7627
[4]   IDENTIFICATION OF A MULTIPROTEIN COMPLEX INTERACTING WITH THE C-FOS SERUM RESPONSE ELEMENT [J].
DEBELLE, I ;
WALKER, PR ;
SMITH, ICP ;
SIKORSKA, M .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (05) :2752-2759
[5]   The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells [J].
Ghannam, G ;
Takeda, A ;
Camarata, T ;
Moore, MA ;
Viale, A ;
Yaseen, NR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (02) :866-875
[6]  
Goodman RH, 2000, GENE DEV, V14, P1553
[7]   HUMAN AND DROSOPHILA HOMEODOMAIN PROTEINS THAT ENHANCE THE DNA-BINDING ACTIVITY OF SERUM RESPONSE FACTOR [J].
GRUENEBERG, DA ;
NATESAN, S ;
ALEXANDRE, C ;
GILMAN, MZ .
SCIENCE, 1992, 257 (5073) :1089-1095
[8]   Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity [J].
Gu, BW ;
Wang, Q ;
Wang, JM ;
Xue, YQ ;
Fang, J ;
Wong, KF ;
Chen, B ;
Shi, ZZ ;
Shi, JY ;
Bai, XT ;
Wu, DH ;
Chen, Z ;
Chen, SJ .
LEUKEMIA, 2003, 17 (09) :1858-1864
[9]   NUP98-Topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation [J].
Gurevich, RM ;
Aplan, PD ;
Humphries, RK .
BLOOD, 2004, 104 (04) :1127-1136
[10]  
Janknecht R, 1996, ONCOGENE, V12, P1961